- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
D. Kyle Sampson
Insight 16 results
Client Alert
April 30, 2020
Congress Enacts OTC Monograph Reform
Client Alert
March 10, 2020
FDA Releases Progress Report Regarding Enforcement Discretion Policy on Hemp-Derived Cannabidiol (CBD)
Client Alert
January 16, 2020
Congress Holds Hearing on Current & Future Federal Cannabis Policies
Article · Source: Law360
January 16, 2020
HHS Drug Import Proposal Is Unlikely To Succeed
Client Alert
January 7, 2020
FDA Issues Proposed Rule and Draft Guidance on Drug Importation
Client Alert
October 31, 2019
USDA Issues Interim Final Rule to Establish Domestic Hemp Production Program and Approve State and Tribal Oversight Plans
Client Alert
August 6, 2019
A Gimmick No More? HHS Moves to Authorize Prescription Drug Importation
Article · Source: Intellectual Property & Technology Law Journal
July 1, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Client Alert
April 9, 2019
FDA Proposes Regulatory Framework for Artificial Intelligence/Machine Learning Software as a Medical Device
Client Alert
April 8, 2019
FDA Regulation of Cannabis
Client Alert
January 22, 2019
FDA Tackles Digital Health Software Devices with New Pre-Certification Review Plan
Client Alert
August 17, 2018
FDA Releases Draft Guidance on Agency Decisions Not to Issue Certificates to Foreign Governments